LINC01922

Across TCGA pan-cancer cohorts, LINC01922 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC01922’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where LINC01922 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01922 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

ESCA, THCA, and KIRC are the cancer types where LINC01922 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01922 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+0.025	.037	2	view →
THCA	Male	All	−0.017	.031	2	view →
KIRC	All	All	+0.009	.015	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

LINC01922–ESCA

Open the ESCA breakdown →